When is the next Pap smear due for an average-risk woman who had a negative Pap test on [DATE]?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Cervical Cancer Screening Interval After Negative Pap Test

For an average-risk woman with a negative Pap test alone (cytology only), the next Pap smear is due in 3 years.

Age-Specific Screening Recommendations

The timing of your next screening depends critically on your age and the type of test performed:

Ages 21-29 Years

  • Cytology (Pap test) alone every 3 years 1, 2
  • HPV testing is not recommended in this age group 1
  • Next Pap due: 3 years from [DATE]

Ages 30-65 Years

You have three acceptable options 1, 2:

  1. Cytology alone every 3 years (if that's what you had)

    • Next Pap due: 3 years from [DATE]
  2. HPV testing alone every 3 years (preferred by ACS 2020)

    • Requires primary HPV test, not reflex HPV testing
  3. Co-testing (Pap + HPV) every 5 years

    • Only if both tests were performed and negative
    • Next screening due: 5 years from [DATE]

The 2020 ACS guidelines now prefer primary HPV testing starting at age 25, but cytology alone and co-testing remain acceptable alternatives 2. The key distinction is that if you had only a Pap test (not co-testing), the interval remains 3 years regardless of age.

Critical Distinctions Based on Test Type

If You Had Pap Test ONLY (Cytology Alone)

  • 3-year interval applies 1
  • This is true whether you're 25 or 55 years old

If You Had Co-testing (Pap + HPV, Both Negative)

  • 5-year interval is appropriate for ages 30-65 1, 2
  • This provides the lowest risk profile for cervical cancer

Special Consideration: HPV-Negative ASC-US

If your result was technically "negative" but showed ASC-US (atypical squamous cells of undetermined significance) with negative HPV, this changes the recommendation:

  • Return for screening in 3 years, not 5 years 3, 4
  • This represents higher risk than truly negative co-testing 3

When to Stop Screening

Age 65 years or older: You may stop screening if you meet both criteria 1:

  • Either 3 consecutive negative Pap tests OR 2 consecutive negative co-tests within the past 10 years
  • AND the most recent test was within the past 5 years

Common Pitfalls to Avoid

  1. Don't confuse reflex HPV testing with co-testing: If HPV was only tested because of an abnormal Pap, this is not co-testing and doesn't qualify for the 5-year interval

  2. Don't screen more frequently than recommended: Annual Pap tests are not recommended and increase harms without improving outcomes 1, 5

  3. Age matters for HPV testing: Women under 30 should not have HPV testing as part of routine screening due to high rates of transient HPV infections 1

  4. Post-hysterectomy: If you've had a hysterectomy with cervix removal and no history of high-grade lesions or cancer, screening should stop entirely 1

The Bottom Line

If you had a standard Pap test (cytology alone) that was negative, schedule your next screening for 3 years from [DATE], regardless of your age between 21-65 years. If you're uncertain whether you had co-testing, check with your provider or review your test results—this distinction determines whether you need screening in 3 versus 5 years.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.